Paraoxonase-2 agonist vutiglabridin promotes autophagy activation and mitochondrial function to alleviate non-alcoholic steatohepatitis.
Shin GC, Lee HM, Kim N, Hur J, Yoo SK, Park YS, Park HS, Ryu D, Park MH, Park JH, Seo SU, Choi LS, Madsen MR, Feigh M, Kim KP, Kim KH.
Shin GC, et al. Among authors: ryu d.
Br J Pharmacol. 2024 Oct;181(19):3717-3742. doi: 10.1111/bph.16438. Epub 2024 Jun 9.
Br J Pharmacol. 2024.
PMID: 38852992